Skip to main content

Biobanks and Research: Scientific Potential and Regulatory Challenge

  • Chapter
  • First Online:
Biobanks and Tissue Research

Abstract

The technical possibilities of automated data analysis of DNA samples and their bioinformatic processing have developed rapidly over the last few years and are constantly being improved. A decade after the completion of a draft human genome sequence was announced, a whole range of possibilities for medical research has unfolded, based on a combination of health and genetic data in so-called biobanks. Biobank research is an essential element of new fields such as epigenetics, metagenetics, and pharmacogenetics. Many European countries have invested considerably in this important research tool, which is expected to further the understanding of the interaction between genes and the environment and its implication for human diseases, as well as the development of efficient medical treatments. However, biobanks will be able to reach their full potential only if certain preconditions are met regarding the harmonization of databank structures and their regulation. The collection and storage of DNA, cell tissue samples as well as the collection of phenotypic, environmental and lifestyle data from medical records and patient questionnaires need to be standardized in order to guarantee sufficient quality of research and to permit collaboration. This process of technical standardization is currently underway. Even more difficult is the harmonization of ethical and legal frameworks. Over the last years, various national and international initiatives have been launched in this respect. This chapter intends to provide an overview of the scientific potential of biobanks and to show the extent to which its realization is dependent on efficient solutions for the regulatory challenges. Europe can only take advantage of the wealth of information contained in its collections of samples and data if the ethical debate about research involving biobanks is adequately resolved. The main goal of this debate is to ensure the protection of the rights of those who have provided the human material, without unduly hampering research. The chapter will outline the most influential regulatory positions, focusing on the recommendations issued by the Council of Europe and the OECD guidelines, and describe the most recent challenges.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    In this chapter, the terms “biobank” and “genetic database” are used interchangeably to signify a collection of human biological samples that can be used for genetic analysis, including those that combine such samples with the results of genetic analyses and health or other data about the persons from whom the samples were collected. The category encompasses pathology collections, repositories for specific diseases (e.g. cancer registries), and population databases created to permit longitudinal studies of any disease or condition (see Elger et al. 2008, p. 1 note 1).

  2. 2.

    Indeed, using existing data and samples for secondary research purposes does not imply direct physical risks and could therefore justify broad, less informed consent.

References

  • Abbott, A. 2003. “With Your Genes? Take One of These, Three Times a Day.” Nature 425 (6960): 760–62.

    PubMed  CAS  Google Scholar 

  • Andorno, R. 2006. “Biobancos poblacionales: un analisis juridico a partir de las experiencias islandesa y Estonia” [Population Bio-Banks: A Juridical Analysis Based on Icelandic and Estonian Experience]. Law and the Human Genome Review 25: 55–76.

    Google Scholar 

  • Asslaber, M., and K. Zatloukal. 2007. “Biobanks: Transnational, European and Global Networks.” Briefings in Functional Genomics and Proteomics 6 (3): 193–201.

    PubMed  Google Scholar 

  • Ballantyne, C. 2008. “Report Urges Europe to Combine Wealth of Biobank Data.” Nature Medicine 14 (7): 701.

    PubMed  Google Scholar 

  • Bardelli, S. 2010. “Stem Cell Biobanks.” Journal of Cardiovascular Translational Research 3 (2): 128–34.

    PubMed  Google Scholar 

  • Belmont Report. 1979. “The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.” The Belmont Report Ethical Principles and Guidelines for the Protection of Human Subjects of Research. April 18, 1979. Accessed March 4, 2011. http://ohsr.od.nih.gov/guidelines/belmont.html

  • Bevilacqua, G., F. Bosman, T. Dassesse, H. Hofler, A. Janin, R. Langer et al. 2010. “The Role of the Pathologist in Tissue Banking: European Consensus Expert Group Report.” Virchows Archiv 456 (4): 449–54.

    PubMed  PubMed Central  Google Scholar 

  • Botling, J., K. Edlund, U. Segersten, S. Tahmasebpoor, M. Engstrom, M. Sundstrom et al. 2009. “Impact of Thawing on RNA Integrity and Gene Expression Analysis in Fresh Frozen Tissue.” Diagnostic Molecular Pathology 18 (1): 44–52.

    PubMed  CAS  Google Scholar 

  • Bovenberg, J., T. Meulenkamp, E. Smets, and S. Gevers. 2009. “Biobank Research: Reporting Results to Individual Participants.” European Journal of Health Law 16 (3): 229–47.

    PubMed  Google Scholar 

  • Butler, D. 2010. “Human Genome at Ten: Science after the Sequence.” Nature 465 (7301): 1000–1.

    PubMed  CAS  Google Scholar 

  • Cardoso, S., L. Valverde, A. Odriozola, X. Elcoroaristizabal, and M. M. de Pancorbo. 2010. “Quality Standards in Biobanking: Authentication by Genetic Profiling of Blood Spots from Donor’s Original Sample.” European Journal of Human Genetics 18 (7): 848–51.

    PubMed  PubMed Central  Google Scholar 

  • Caulfield, T., and C. Weijer. 2009. “Minimal Risk and Large-Scale Biobank and Cohort Research.” Health Law Review 17 (2–3): 53–58.

    Google Scholar 

  • Chabannon, C., A. Honstettre, L. M. Daufresne, P. M. Martin, C. Bonnetaud, I. Birtwisle-Peyrottes et al. 2010. “Publication of Biological Samples Collections Catalogues by Tumor Banks.” Bull Cancer 97 (2): 181–89.

    PubMed  CAS  Google Scholar 

  • Chung, T. H., J. H. Yoo, J. C. Ryu, and Y. S. Kim. 2009. “Recent Progress in Toxicogenomics Research in South Korea.” BMC Proceedings 3 (Suppl. 2): S6.

    PubMed  PubMed Central  Google Scholar 

  • Clement, B., G. Chene, and F. Degos. 2009. “A National Collection of Liver Tumours: Lessons Learnt from 6 Years of Biobanking in France.” Cancer Letters.

    Google Scholar 

  • COE. 2005. “Additional Protocol to the Convention on Human Rights and Biomedicine, Concerning Biomedical Research Strasbourg,” 25.I.2005. Accessed March 2, 2011. http://conventions.coe.int/Treaty/en/Treaties/Html/195.htm

  • COE. 2006. “Council of Europe. Rec(2006)4 of the Committee of Ministers to Member States on Research on Biological Materials of Human Origin.” Accessed March 2, 2011. http://wcd.coe.int/ViewDoc.jsp?id=977859

  • Data Protection Working Party. 2007. “Opinion 4/2007 on the Concept of Personal Data.” Article 29, WP 136. Brussels: European Commission. Accessed March 2, 2011. http://ec.europa.eu/justice_home/fsj/privacy/docs/wpdocs/2007/wp136_en.pdf

  • Day, J. G., and G. N. Stacey. 2008. “Biobanking.” Molecular Biotechnology 40 (2): 202–13.

    PubMed  CAS  Google Scholar 

  • Deplanque, D., G. Birraux, P. H. Bertoye, and E. Postaire. 2009. “Collections of Human Biological Samples for Scientific Purposes. Why Do Current Regulation Need to be Clarified and How?” Therapie 64 (4): 259–67.

    PubMed  Google Scholar 

  • Diez, D., A. M. Wheelock, S. Goto, J. Z. Haeggstrom, G. Paulsson-Berne, G. K. Hansson et al. 2010. “The Use of Network Analyses for Elucidating Mechanisms in Cardiovascular Disease.” Molecular Biosystems 6 (2): 289–304.

    PubMed  CAS  Google Scholar 

  • Durham, N. P., and A. S. Hall. 1999. “Genes and the Heart: A Quest for New Therapeutic Strategies. Cambridge Healthtech Institute’s First Cardiovascular Genomics Conference. Orlando, FL, USA, 11–12 January 1999.” Molecular Medicine Today 5 (5): 195–97.

    PubMed  CAS  Google Scholar 

  • Ebner, A., J. R. Thyrian, A. Lange, M. L. Lingnau, M. Scheler-Hofmann, D. Rosskopf et al. 2010. “Survey of Neonates in Pomerania (SNiP): A Population-Based Birth Study – Objectives, Design and Population Coverage.” Paediatric and Perinatal Epidemiology 24 (2): 190–99.

    PubMed  Google Scholar 

  • Elger, B., N. Biller-Andorno, A. Mauron, and A. M. Capron (Eds.). 2008. Ethical Issues in Governing Biobanks: Global Perspectives. London: Ashgate.

    Google Scholar 

  • Elger, B. S. 2010. Ethical Issues of Human Genetic Databases: A Challenge to Classical Health Research Ethics? London: Ashgate.

    Google Scholar 

  • Elger, B. S., and A. L. Caplan. 2006. “Consent and Anonymization in Research Involving Biobanks: Differing Terms and Norms Present Serious Barriers to an International Framework.” European Molecular Biology Organization Reports 7 (7): 661–66.

    PubMed  CAS  Google Scholar 

  • Ennis, D. P., G. P. Pidgeon, N. Millar, N. Ravi, and J. V. Reynolds. 2009. “Building a Bioresource for Esophageal Research: Lessons from the Early Experience of an Academic Medical Center.” Diseases of the Esophagus.

    Google Scholar 

  • Enserink, M. 1998a. “Opponents Criticize Iceland’s Database.” Science 282 (5390): 859.

    PubMed  CAS  Google Scholar 

  • Enserink, M. 1998b. “Physicians Wary of Scheme to Pool Icelanders’ Genetic Data.” Science 281 (5379): 890–91.

    PubMed  CAS  Google Scholar 

  • European Science Foundation. 2008. “Population Surveys and Biobanking.” Accessed March 2, 2011. http://www.esf.org/publications/science-policy-briefings.html

  • Forsberg, J. S., M. G. Hansson, and S. Eriksson. 2009. “Changing Perspectives in Biobank Research: From Individual Rights to Concerns about Public Health Regarding the Return of Results.” European Journal of Human Genetics.

    Google Scholar 

  • Garcia-Merino, I., N. de Las Cuevas, J. L. Jimenez, A. Garcia, J. Gallego, C. Gomez. et al. 2010. “Pediatric HIV BioBank: A New Role of the Spanish HIV BioBank in Pediatric HIV Research.” AIDS Research and Human Retroviruses 26 (2): 241–44.

    PubMed  Google Scholar 

  • Goebel, J. W., T. Pickardt, M. Bedau, M. Fuchs, C. Lenk, I. Paster et al. 2010. “Legal and Ethical Consequences of International Biobanking from a National Perspective: The German BMB-EUCoop Project.” European Journal of Human Genetics 18 (5): 522–25.

    PubMed  Google Scholar 

  • Gurwitz, D., I. Fortier, J. E. Lunshof, and B. M. Knoppers. 2009. “Research Ethics: Children and Population Biobanks.” Science 325 (5942): 818–19.

    PubMed  Google Scholar 

  • Gurwitz, D., J. E. Lunshof, G. Dedoussis, C. S. Flordellis, U. Fuhr, J. Kirchheiner et al. 2005. “Pharmacogenomics Education: International Society of Pharmacogenomics Recommendations for Medical, Pharmaceutical, and Health Schools Deans of Education.” Pharmacogenomics Journal 5 (4): 221–25.

    PubMed  CAS  Google Scholar 

  • Gurwitz, D., and M. Pirmohamed. 2010. “Pharmacogenomics: The Importance of Accurate Phenotypes.” Pharmacogenomics 11 (4): 469–70.

    PubMed  CAS  Google Scholar 

  • ISBER. 2009. International Society for Biological and Environmental Repositories. Accessed March 2, 2011. http://www.isber.org/

  • Jiang, C. Q., T. H. Lam, J. M. Lin, B. Liu, X. J. Yue, K. K. Cheng et al. 2009. “An Overview of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort (GBCS-CVD): A Platform for Multidisciplinary Collaboration.” Journal of Human Hypertension 24 (2): 139–50.

    PubMed  Google Scholar 

  • Johnsen, I. K., S. Hahner, J. J. Briere, A. Ozimek, A. P. Gimenez-Roqueplo, C. Hantel et al. 2009. “Evaluation of a Standardized Protocol for Processing Adrenal Tumor Samples: Preparation for a European Adrenal Tumor Bank.” Hormone and Metabolic Research 42 (2): 93–101.

    PubMed  Google Scholar 

  • Jones, D. A., and C. MacKellar. 2009. “Consent for Biobank Tissue in Somatic-Cell Nuclear Transfer.” Lancet 374 (9693): 861–63.

    PubMed  Google Scholar 

  • Kaiser, J. 2002. “Biobanks: Population Databases Boom, from Iceland to the U.S.” Science 298 (5596): 1158–61.

    PubMed  CAS  Google Scholar 

  • Kapeu, A. S., T. Luostarinen, E. Jellum, J. Dillner, M. Hakama, P. Koskela et al. 2009. “Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.” American Journal of Epidemiology 169 (4): 480–488.

    PubMed  Google Scholar 

  • Kavikondala, S., C. Q. Jiang, W. S. Zhang, K. K. Cheng, T. H. Lam, G. M. Leung et al. 2010. “Intergenerational ‘Mismatch’ and Adiposity in a developing population: The Guangzhou Biobank Cohort Study.” Social Science and Medicine 70 (6): 834–43.

    PubMed  Google Scholar 

  • Knoppers, B. M., Y. Joly, J. Simard, and F. Durocher. 2006. “The Emergence of an Ethical Duty to Disclose Genetic Research Results: International Perspectives.” European Journal of Human Genetics 14 (11): 1170–78.

    PubMed  Google Scholar 

  • Langseth, H., T. Luostarinen, F. Bray, and J. Dillner. 2010. “Ensuring Quality in Studies Linking Cancer Registries and Biobanks.” Acta Oncology 49 (3): 368–77.

    Google Scholar 

  • Latourelle, J. C., N. Pankratz, A. Dumitriu, J. B. Wilk, S. Goldwurm, G. Pezzoli et al. 2009. “Genomewide Association Study for Onset Age in Parkinson Disease.” BMC Medical Genetics 10: 98.

    PubMed  PubMed Central  Google Scholar 

  • Lefrere, J. J., and N. Coudurier. 2009. “Biobanks and Blood Transfusion in France: A Tool for Public Health.” Transfusion Clinique et Biologique 16 (2): 148–51.

    PubMed  Google Scholar 

  • Lemonick, M. D. 2006. “The Iceland Experiment: How a Tiny Island Nation Captured the Lead in the Genetic Revolution.” Time 167 (8): 50–51.

    PubMed  Google Scholar 

  • Matimba, A., J. Del-Favero, C. Van Broeckhoven, and C. Masimirembwa. 2009. “Novel Variants of Major Drug-Metabolising Enzyme Genes in Diverse African Populations and their Predicted Functional Effects.” Human Genomics 3 (2): 169–90.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Meslin, E. M. 2010. “The Value of Using Top-Down and Bottom-Up Approaches for Building Trust and Transparency in Biobanking.” Public Health Genomics 13 (4): 207–14.

    PubMed  PubMed Central  Google Scholar 

  • Mitchell, R. 2010. “National Biobanks: Clinical Labor, Risk Production, and the Creation of Biovalue.” Science Technology and Human Values 35 (3): 330–55.

    Google Scholar 

  • Modin, C., B. Bjerregaard, T. Orntoft, and E. Hogdall. 2010. “Establishing the Danish CancerBiobank.” Ugeskrift for laeger 172 (19): 1446–50.

    PubMed  Google Scholar 

  • National Bioethics Advisory Commission [NBAC]. 1999. Research Involving Human Biological Materials: Ethical Issues and Policy Guidance, Report and Recommendations, vol. 1. Rockville: National Bioethics Advisory Commission.

    Google Scholar 

  • NCI. 2007. “Best Practices for Biospecimen Resources.” Accessed March 2, 2011. http://www.allirelandnci.org/pdf/NCI_Best_Practices_060507.pdf

  • Netzer, C., and N. Biller-Andorno. 2004. “Pharmacogenetic Testing, Informed Consent and the Problem of Secondary Information.” Bioethics 18 (4): 344–60.

    PubMed  Google Scholar 

  • Nutley, N. J. 2002. Roche and deCODE Unveil New Alliance in Drug Discovery and Development. Current News Releases January 29, 2002. Accessed March 2, 2011. http://www.datamonitor.com/store/news/roche_and_decode_unveil_new_alliance_in_drug_discovery_and_development?productid=2DEA0EE0-08B6-4FE7-97A3-EE821B8848DD

  • O’Brien, S. J. 2009. “Stewardship of Human Biospecimens, DNA, Genotype, and Clinical Data in the GWAS Era.” Annual Review of Genomics and Human Genetics.

    Google Scholar 

  • OECD. 2009. “Guidelines on Human Biobanks and Genetic Research Databases.” Paris: OECD. Accessed March 2, 2011. http://www.oecd.org/document/12/0,3343,en_2649_34537_40302092_1_1_1_1,00&&en-USS_01DBC.html

  • OHRP. 2004. Guidance on Research Involving Coded Private Information or Biological Specimens. Rockville: Office for Human Research Protections.

    Google Scholar 

  • Ottenhoff, T. H. 2009. “Overcoming the Global Crisis: “Yes, We Can”, But Also for TB?” European Journal of Immunology 39 (8): 2014–20.

    PubMed  CAS  Google Scholar 

  • Posch, M. G., G. Gelbrich, B. Pieske, E. Lehmkuhl, C. E. Angermann, S. Stork et al. 2009. “The Biomaterialbank of the German Competence Network of Heart Failure (CNHF) Is a Valuable Resource for Biomedical and Genetic Research.” International Journal of Cardiology 136 (1): 108–11.

    PubMed  Google Scholar 

  • Reed, W., and R. Bjugn. 2010. “Good Biobanks for Better Health.” Tidsskr Nor Laegeforen 130 (11): 1156–58.

    PubMed  Google Scholar 

  • Riegman, P. H., B. W. de Jong, and A. Llombart-Bosch. 2010. “The Organization of European Cancer Institute Pathobiology Working Group and its Support of European Biobanking Infrastructures for Translational Cancer Research.” Cancer Epidemiology, Biomarkers and Prevention 19 (4): 923–26.

    PubMed  Google Scholar 

  • Ritchie, M. D., J. C. Denny, D. C. Crawford, A. H. Ramirez, J. B. Weiner, J. M. Pulley et al. 2010. “Robust Replication of Genotype-Phenotype Associations Across Multiple Diseases in an Electronic Medical Record.” American Journal of Human Genetics 86 (4): 560–72.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Rose, H. 2006. “From Hype to Mothballs in Four Years: Troubles in the Development of Large-Scale DNA Biobanks in Europe.” Community Genetics 9 (3): 184–89.

    PubMed  Google Scholar 

  • Rudan, I., A. Marusic, S. Jankovic, K. Rotim, M. Boban, G. Lauc et al. 2009. “ ‘10001 Dalmatians’: Croatia Launches Its National Biobank.” Croatian Medical Journal 50 (1): 4–6.

    PubMed  PubMed Central  Google Scholar 

  • Rudloff, U., U. Bhanot, W. Gerald, D. S. Klimstra, W. R. Jarnagin, M. F. Brennan et al. 2010. “Biobanking of Human Pancreas Cancer Tissue: Impact of Ex-Vivo Procurement Times on RNA Quality.” Annals of Surgical Oncology 17 (8): 2229–36.

    PubMed  Google Scholar 

  • Salvaterra, E., L. Lecchi, S. Giovanelli, B. Butti, M. T. Bardella, P. A. Bertazzi et al. 2008. “Banking Together: A Unified Model of INFORMED Consent for Biobanking.” European Molecular Biology Organization Reports 9 (4): 307–13.

    PubMed  CAS  Google Scholar 

  • Schwartz, J. 1999. “For Sale in Iceland: A Nation’s Genetic Code.” Washington Post. January 12, 1999. Accessed March 4, 2011. http://www.highbeam.com/doc/1P2-572603.html

  • Secko, D. M., N. Preto, S. Niemeyer, and M. M. Burgess. 2009. “Informed Consent in Biobank Research: A Deliberative Approach to the Debate.” Social Science and Medicine 68 (4): 781–89.

    PubMed  Google Scholar 

  • Talens, R. P., D. I. Boomsma, E. W. Tobi, D. Kremer, J. W. Jukema, G. Willemsen et al. 2010. “Variation, Patterns, and Temporal Stability of DNA Methylation: Considerations for Epigenetic Epidemiology.” The FASEB Journal.

    Google Scholar 

  • Teunissen, C. E., A. Petzold, J. L. Bennett, F. S. Berven, L. Brundin, M. Comabella et al. 2009. “A Consensus Protocol for the Standardization of Cerebrospinal Fluid Collection and Biobanking.” Neurology 73 (22): 1914–22.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Vlastos, F., S. Lacomme, P. Wild, S. Poulain, J. Siat, G. Grosdidier et al. 2009. “Do evolving practices improve survival in operated lung cancer patients? A biobank may answer.” Journal of Thorac Oncology 4 (4): 505–511.

    Google Scholar 

  • Williams, R., C. Mant, and J. Cason. 2009. “The Infectious Diseases BioBank at King’s College London: Archiving Samples from Patients Infected with HIV to Facilitate Translational Research.” Retrovirology 6: 98.

    PubMed  PubMed Central  Google Scholar 

  • WMA. 2008. “WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects.” 59th WMA General Assembly, Seoul, October 2008. Accessed March 4, 2011. http://www.wma.net/fr/20activities/10ethics/10helsinki/

  • Womack, C., and N. M. Gray. 2009. “Banking Human Tissue for Research: Vision to Reality.” Cell and Tissue Banking 10 (3): 267–70.

    PubMed  CAS  Google Scholar 

  • Yuille, M., K. Dixon, A. Platt, S. Pullum, D. Lewis, A. Hall et al. 2009. “The UK DNA Banking Network: A ‘Fair Access’ Biobank.” Cell and Tissue Banking 11 (3): 241–51.

    PubMed  PubMed Central  Google Scholar 

  • Zika, E., D. Paci, A. Braun, S. Rijkers-Defrasne, M. Deschenes, I. Fortier et al. 2010. “A European Survey on Biobanks: Trends and Issues.” Public Health Genomics.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernice S. Elger .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Elger, B.S., Biller-Andorno, N. (2011). Biobanks and Research: Scientific Potential and Regulatory Challenge. In: Lenk, C., Sándor, J., Gordijn, B. (eds) Biobanks and Tissue Research. The International Library of Ethics, Law and Technology, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1673-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-1673-5_3

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-1672-8

  • Online ISBN: 978-94-007-1673-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics